Lipid nanoparticles (LNPs) act as carriers for mRNA and CRISPR payloads across a wide range of therapeutic applications, from cancer to inflammatory and genetic diseases. The same delivery system used ...

Engineers at the University of Pennsylvania have developed LIBRIS, an automated microfluidic platform that dramatically ...

Thanks to advances in imaging and diagnostic technologies, clinicians can now detect many genetic disorders in the womb, ...

Scientists at UC Berkeley have discovered a microbe that bends one of biology’s most sacred rules. Instead of treating a specific three-letter DNA code as a clear “stop” signal, this methane-producing ...

Full Circles Therapeutics today announced that its circular single-stranded DNA (cssDNA, C4DNAtm) technology platform has been highlighted as a key enabling component of a new genome engineering ...

Funding to accelerate internal pipeline and advance lead antibody programs toward in vivo efficacy studiesAI-driven, lab-in-the-loop platform designs, builds, and validates therapeutic-strength ...

Lipid nanoparticles, or LNPs, are best known as the delivery system used in the COVID-19 mRNA vaccines given to billions of people worldwide. Scientists are now exploring their potential far beyond ...

Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution. Researchers ...

Explore the future of gene therapy delivery with lipid nanoparticles. Learn how they can transform treatments for various diseases.

Advances in organ and computer models are raising the prospect that some animal experiments could be eliminated. But there ...

On a typical day, they greet farmers bringing them ticks, real estate agents with mysterious roaches and anxious homeowners ...